articles
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets. 178:S1-S26. 2021
- Paradoxical changes in brain reward status during oxycodone self-administration in a novel test of the negative reinforcement hypothesis. 178:3797-3812. 2021
- Sex-dependent effects of endocannabinoid modulation of conditioned fear extinction in rats. 178:983-996. 2021
- B-1 and B-2 kinin receptor blockade improves psoriasis-like disease 2020
- NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area 2020
- Lasting effects of repeated ∆9 -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats 2020
- The BJP expects authors to share data. 176:4595-4598. 2019
- Sex differences in mouse models of fear inhibition: Fear extinction, safety learning, and fear-safety discrimination. 176:4149-4158. 2019
- Sex: A change in our guidelines to authors to ensure that this is no longer an ignored experimental variable 2019
- Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats. 176:1524-1540. 2019
- A novel inhibitor of inducible NOS dimerization protects against cytokine-induced rat beta cell dysfunction. 175:3470-3485. 2018
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. 175:987-993. 2018
- Robust anti-nociceptive effects of monoacylglycerol lipase inhibition in a model of osteoarthritis pain. 173:3134-3144. 2016
- Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P(1)) and receptor-5 (S1P(5)) agonist with autoimmune disease-modifying activity. 173:1778-1792. 2016
- Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain. 173:1678-1692. 2016
- Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo. 173:1438-1451. 2016
- Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9)-tetrahydrocannabinol in Sprague-Dawley rats. 172:1783-1791. 2015
- AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation. 172:1292-1304. 2015
- Inhibition of monoacylglycerol lipase reduces nicotine withdrawal. 172:869-882. 2015
- Lysophospholipid receptor nomenclature review: IUPHAR Review 8. 171:3575-3594. 2014
- In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects. 171:1392-1407. 2014
- Functional pharmacology of H-1 histamine receptors expressed in mouse preoptic/anterior hypothalamic neurons. 170:415-425. 2013
- A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects. 169:784-793. 2013
- Cannabidiol attenuates deficits of visuo-spatial associative memory induced by Δ9 tetrahydrocannabinol 2013
- β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors. 166:1474-1489. 2012
- Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats. 165:2425-2435. 2012
- The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. 165:2485-2496. 2012
- Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice. 165:1556-1571. 2012
- Insights into the pharmacological relevance of lysophospholipid receptors. 165:829-844. 2012
- Mephedrone (4-methylmethcathinone) and d-methamphetamine improve visuospatial associative memory, but not spatial working memory, in rhesus macaques. 167:1342-1352. 2012
- Systemic urocortin 2, but not urocortin 1 or stressin1-a, suppresses feeding via crf2 receptors without malaise and stress. 164:1959-1975. 2011
- Cox-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation. 164:1672-1683. 2011
- Reviewer comments on Reflections on drug research by Sir James Black. 161:1217-1217. 2010
- Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase. 160:549-560. 2010
- Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. 160:423-442. 2010
- The phospholipase A(2) inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice. 157:1263-1269. 2009
- Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. 153:140-147. 2008
- Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells. 142:150-160. 2004
- Evidence in locomotion test for the functional heterogeneity of orl-1 receptors. 141:132-140. 2004
- Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. 141:241-252. 2004
- Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor. 139:575-584. 2003
- Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs. 139:109-121. 2003
- Nociceptin (1-7) antagonizes nociceptin-induced hyperalgesia in mice. 128:941-944. 1999
- Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells. 128:613-620. 1999
- Antagonistic action of pitrazepin on human and rat gaba(a) receptors. 127:57-64. 1999
- The role of alpha(2)-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat. 124:1550-1556. 1998
- The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. 124:889-896. 1998
- Identification and pharmacological characterization of somatostatin receptors in rat lung. 121:963-971. 1997
- New high affinity peptide antagonists to the spinal galanin receptor. 116:2076-2080. 1995
- Functional-effects of long-term activation on human beta(2)-adrenoceptor and beta(3)-adrenoceptor signaling. 114:1045-1051. 1995
- Mediation of most atypical effects by species homologs of the beta(3)-adrenoceptor. 112:911-919. 1994
- Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types. 111:1129-1134. 1994
- Evidence for a functional beta(3)-adrenoceptor in man. 110:929-936. 1993
- Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus. 103:1719-1724. 1991
- Responsiveness of platelets and coronary-arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogs. 78:287-292. 1983